Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Reverse split

<< Previous

Bullboard Posts

Next >>

Post by wetbehindearson Apr 03, 2021 8:54am

292 Views

Post# 32933467

Reverse split

again...new to this but invested...if I'm wrong let me know..

Having the reverse split happen before a dramatic increase in stock price would really hurt. It is the number of stocks we have that can create the value, not the pennies each share is worth

if I have 500k shares at 4.5 cents and there is a reserve split that now has me at 250k at 9 cents no 'value' is lost. However, if the share price then goes to $1, I will have $250k in value not $500k

So if there a chance of an increase in share price before the reverse split?

Sorry for my 'wet behind the ears' question

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide